Radiotherapy for laryngeal cancers
| Autor: | J. Biau, Y. Pointreau, P. Blanchard, C. Khampan, P. Giraud, M. Lapeyre, P. Maingon |
|---|---|
| Přispěvatelé: | Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA) |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
MESH: Radiation-Sensitizing Agents
Radiation-Sensitizing Agents Intensity-modulated radiotherapy Recommandations MESH: Laryngeal Neoplasms Laryngectomy [SDV.CAN]Life Sciences [q-bio]/Cancer Radiothérapie conformationnelle avec modulation d’intensité Recommendations MESH: Postoperative Care Doses Délinéation Humans Radiology Nuclear Medicine and imaging Laryngeal Neoplasms Neoplasm Staging Postoperative Care MESH: Humans MESH: Organ Sparing Treatments Larynx cancer Induction Chemotherapy Delineation MESH: Radiotherapy Intensity-Modulated MESH: Neoplasm Staging MESH: Laryngectomy MESH: Radiation Oncology MESH: Induction Chemotherapy Indication MESH: France Tumeurs laryngée Oncology MESH: Cisplatin Dose Radiation Oncology Dose Fractionation Radiation France Radiotherapy Intensity-Modulated Cisplatin Indications MESH: Dose Fractionation Radiation Tomography X-Ray Computed MESH: Tomography X-Ray Computed Organ Sparing Treatments MESH: Radiotherapy Image-Guided Radiotherapy Image-Guided Société française de radiothérapie oncologique |
| Zdroj: | Cancer/Radiothérapie Cancer/Radiothérapie, 2022, 26 (1-2), pp.206-212. ⟨10.1016/j.canrad.2021.09.004⟩ |
| ISSN: | 1278-3218 1769-6658 |
| DOI: | 10.1016/j.canrad.2021.09.004⟩ |
| Popis: | International audience; We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of laryngeal cancers. Early stage T1 or T2 tumours can be treated either by radiotherapy or conservative surgery. For tumours requiring total laryngectomy (T2 or T3), an organ preservation strategy by either induction chemotherapy followed by radiotherapy or chemoradiotherapy with cisplatin is recommended. For T4 tumours, a total laryngectomy followed by radiotherapy is recommended when feasible. Dose regimens for definitive and postoperative radiotherapy are detailed in this article, as well as the selection and delineation of tumour and lymph node target volumes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect